Improvement of Systemic Sclerosis Complicated with Interstitial Lung Disease by Intravenous Pulse Therapy with Cyclophosphamide

Nishi Nihon Hifuka ◽

10.2336/nishinihonhifu.68.256 ◽

2006 ◽

Vol 68 (3) ◽

pp. 256-259 ◽

Author(s):

Yumi MURASE ◽

Jun KURODA ◽

Yoshinao MURO ◽

Yasushi TOMITA

Keyword(s):

Systemic Sclerosis ◽

Interstitial Lung Disease ◽

Lung Disease ◽

Download Full-text

A Case of Systemic Sclerosis with Interstitial Lung Disease Successfully Treated with Intravenous Cyclophosphamide Pulse Therapy and Oral Azathioprine

Nishi Nihon Hifuka ◽

10.2336/nishinihonhifu.78.356 ◽

2016 ◽

Vol 78 (4) ◽

pp. 356-361

Author(s):

Kei YAMAUCHI ◽

Katsunari MAKINO ◽

Takamitsu MAKINO ◽

Satoshi FUKUSHIMA ◽

Masatoshi JINNIN ◽

...

Keyword(s):

Systemic Sclerosis ◽

Interstitial Lung Disease ◽

Lung Disease ◽

Pulse Therapy ◽

Intravenous Cyclophosphamide ◽

Cyclophosphamide Pulse Therapy ◽

Cyclophosphamide Pulse

Download Full-text

Prediction of therapeutic response before and during i.v. cyclophosphamide pulse therapy for interstitial lung disease in systemic sclerosis: A longitudinal observational study

The Journal of Dermatology ◽

10.1111/1346-8138.14669 ◽

2018 ◽

Vol 45 (12) ◽

pp. 1425-1433 ◽

Author(s):

Hayakazu Sumida ◽

Yoshihide Asano ◽

Zenshiro Tamaki ◽

Naohiko Aozasa ◽

Takashi Taniguchi ◽

...

Keyword(s):

Systemic Sclerosis ◽

Interstitial Lung Disease ◽

Observational Study ◽

Lung Disease ◽

Therapeutic Response ◽

Pulse Therapy ◽

Cyclophosphamide Pulse Therapy ◽

Longitudinal Observational Study ◽

Cyclophosphamide Pulse

Download Full-text

FRI0385 Long term follow-up after systemic sclerosis patients treated with intravenous cyclophosphamide pulse therapy for interstitial lung disease: a single eustar center (042) experience.

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2013-eular.1512 ◽

2013 ◽

Vol 72 (Suppl 3) ◽

pp. A503.3-A503

Author(s):

A. Balbir-Gurman ◽

L. Guralnik ◽

M. Yigla ◽

E. Hardak ◽

A. Solomonov ◽

...

Keyword(s):

Systemic Sclerosis ◽

Interstitial Lung Disease ◽

Lung Disease ◽

Pulse Therapy ◽

Intravenous Cyclophosphamide ◽

Cyclophosphamide Pulse Therapy ◽

Long Term Follow Up ◽

Cyclophosphamide Pulse

Download Full-text

Efficacy and safety of intravenous cyclophosphamide pulse therapy with oral prednisolone in the treatment of interstitial lung disease with systemic sclerosis: 4-year follow-up

Modern Rheumatology ◽

10.3109/s10165-010-0403-6 ◽

2011 ◽

Vol 21 (3) ◽

pp. 296-301 ◽

Author(s):

Akiko Tochimoto ◽

Yasushi Kawaguchi ◽

Masako Hara ◽

Mutsuto Tateishi ◽

Chikako Fukasawa ◽

...

Keyword(s):

Systemic Sclerosis ◽

Interstitial Lung Disease ◽

Lung Disease ◽

Oral Prednisolone ◽

Pulse Therapy ◽

Efficacy And Safety ◽

Intravenous Cyclophosphamide ◽

Cyclophosphamide Pulse Therapy ◽

Cyclophosphamide Pulse

Download Full-text

P49 Intravenous cyclophosphamide pulse therapy with oral prednisolone for the treatment of interstitial lung disease secondary to systemic sclerosis

Indian Journal of Rheumatology ◽

10.1016/s0973-3698(10)60278-6 ◽

2006 ◽

Vol 1 (3) ◽

pp. 163

Author(s):

SK Sharma ◽

A Wanchu ◽

P Bambery

Keyword(s):

Systemic Sclerosis ◽

Interstitial Lung Disease ◽

Lung Disease ◽

Oral Prednisolone ◽

Pulse Therapy ◽

Intravenous Cyclophosphamide ◽

Cyclophosphamide Pulse Therapy ◽

Cyclophosphamide Pulse

Download Full-text

Does high-dose extended course cyclophosphamide and methylprednisolone pulse therapy have a role in the management of systemic sclerosis-related interstitial lung disease?

Rheumatology ◽

10.1093/rheumatology/kew362 ◽

2016 ◽

Vol 55 (12) ◽

pp. 2273-2275 ◽

Author(s):

Giuseppina Abignano ◽

Lesley-Anne Bissell ◽

Paul Emery ◽

Francesco Del Galdo ◽

Maya H. Buch

Keyword(s):

Systemic Sclerosis ◽

Interstitial Lung Disease ◽

Lung Disease ◽

Pulse Therapy ◽

Methylprednisolone Pulse Therapy ◽

High Dose ◽

Methylprednisolone Pulse ◽

Extended Course

Download Full-text

Intravenous Cyclophosphamide Pulse Therapy in the Treatment of Systemic Sclerosis-Related Interstitial Lung Disease: A Long Term Study

The Open Respiratory Medicine Journal ◽

10.2174/1874306400802010039 ◽

2008 ◽

Vol 2 (1) ◽

pp. 39-45 ◽

Author(s):

C. Simeon-Aznar

Keyword(s):

Systemic Sclerosis ◽

Interstitial Lung Disease ◽

Lung Disease ◽

Pulse Therapy ◽

Intravenous Cyclophosphamide ◽

Cyclophosphamide Pulse Therapy ◽

Long Term Study ◽

Cyclophosphamide Pulse

Download Full-text

Rapid alteration of serum interleukin-6 levels may predict the reactivity of i.v. cyclophosphamide pulse therapy in systemic sclerosis-associated interstitial lung disease

The Journal of Dermatology ◽

10.1111/1346-8138.14580 ◽

2018 ◽

Vol 45 (10) ◽

pp. 1221-1224 ◽

Author(s):

Hiroko Numajiri ◽

Ayumi Yoshizaki ◽

Takemichi Fukasawa ◽

Satoshi Ebata ◽

Kouki Nakamura ◽

...

Keyword(s):

Systemic Sclerosis ◽

Interstitial Lung Disease ◽

Lung Disease ◽

Interleukin 6 ◽

Pulse Therapy ◽

Cyclophosphamide Pulse Therapy ◽

Cyclophosphamide Pulse

Download Full-text

Successful use of intravenous cyclophosphamide pulse therapy for interstitial lung disease in a patient with systemic sclerosis on hemodialysis

The Journal of Dermatology ◽

10.1111/1346-8138.12495 ◽

2014 ◽

Vol 41 (6) ◽

pp. 533-535

Author(s):

Takehiro Takahashi ◽

Yoshihide Asano ◽

Ryo Sunaga ◽

Yohei Ichimura ◽

Takashi Taniguchi ◽

...

Keyword(s):

Systemic Sclerosis ◽

Interstitial Lung Disease ◽

Lung Disease ◽

Pulse Therapy ◽

Intravenous Cyclophosphamide ◽

Cyclophosphamide Pulse Therapy ◽

Cyclophosphamide Pulse

Download Full-text

Faculty Opinions recommendation of Interstitial lung disease in systemic sclerosis: a simple staging system.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1108827.576910 ◽

2008 ◽

Author(s):

Oliver Distler

Keyword(s):

Systemic Sclerosis ◽

Interstitial Lung Disease ◽

Lung Disease ◽

Download Full-text